Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$461M |
| 2 |
American Tower
AMT
|
+$401M |
| 3 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$399M |
| 4 |
US Bancorp
USB
|
+$346M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$316M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$589M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$506M |
| 3 |
Lockheed Martin
LMT
|
+$418M |
| 4 |
RTN
Raytheon Company
RTN
|
+$373M |
| 5 |
Procter & Gamble
PG
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.78% |
| 2 | Healthcare | 12.43% |
| 3 | Financials | 11.93% |
| 4 | Consumer Discretionary | 9.96% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Comstock Resources
CRK
$3.89B
| $1.32M | ﹤0.01% |
300,690
+202,861
| +207% | +$1.21M |
|
|
CFB
2552
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $1.32M | ﹤0.01% |
134,469
+5,721
| +4% | +$52.3K |
|
2553
Transmedics
TMDX
$2.64B
| $1.31M | ﹤0.01% |
72,923
+19,429
| +36% | +$304K |
|
|
STSA
2554
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $1.31M | ﹤0.01% |
45,445
+15,570
| +52% | +$360K |
|
2555
Atlanta Braves Holdings Series A
BATRA
$3.49B
| $1.3M | ﹤0.01% |
64,946
+5,849
| +10% | +$119K |
|
|
FPRX
2556
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $1.3M | ﹤0.01% |
213,626
-1,289
| -0.6% | -$5.31K |
|
2557
Arlo Technologies
ARLO
$1.6B
| $1.28M | ﹤0.01% |
496,139
+38,969
| +9% | +$94.1K |
|
2558
CEL-SCI Corp
CVM
$20.3M
| $1.27M | ﹤0.01% |
2,846
-47
| -2% | -$19.3K |
|
|
AKRO
2559
DELISTED
Akero Therapeutics
AKRO
| $1.27M | ﹤0.01% |
50,945
+6,619
| +15% | +$151K |
|
2560
Greenlight Captial
GLRE
$552M
| $1.27M | ﹤0.01% |
194,153
+11,903
| +7% | +$77.9K |
|
|
NVO
2561
Novo Nordisk
NVO
$208B
| $1.26M | ﹤0.01% |
38,584
-82,886
| -68% | -$2.64M |
|
2562
Noodles & Co
NDLS
$111M
| $1.25M | ﹤0.01% |
25,851
+2,391
| +10% | +$102K |
|
|
TAST
2563
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $1.24M | ﹤0.01% |
255,400
+16,857
| +7% | +$63.6K |
|
|
CODX
2564
Co-Diagnostics
CODX
$5.31M
| $1.24M | ﹤0.01% |
+2,126
| New | +$970K |
|
2565
Carter Bankshares
CARE
$766M
| $1.23M | ﹤0.01% |
152,079
+12,639
| +9% | +$102K |
|
2566
Neurogene
NGNE
$656M
| $1.23M | ﹤0.01% |
3,698
+2,995
| +426% | +$781K |
|
2567
FuelCell Energy
FCEL
$1.73B
| $1.22M | ﹤0.01% |
17,945
+15,296
| +577% | +$943K |
|
|
ATHX
2568
DELISTED
Athersys, Inc. Common Stock
ATHX
| $1.22M | ﹤0.01% |
17,633
+4,356
| +33% | +$303K |
|
|
HTZ
2569
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $1.22M | ﹤0.01% |
862,227
-167,757
| -16% | -$532K |
|
2570
Acacia Research
ACTG
$428M
| $1.21M | ﹤0.01% |
295,382
+7,553
| +3% | +$21.9K |
|
2571
UNIFI
UFI
$119M
| $1.2M | ﹤0.01% |
93,463
+4,714
| +5% | +$55.8K |
|
2572
United States Lime & Minerals
USLM
$3.16B
| $1.2M | ﹤0.01% |
71,100
+3,440
| +5% | +$53.7K |
|
|
WOW
2573
DELISTED
WideOpenWest
WOW
| $1.2M | ﹤0.01% |
227,594
+70,350
| +45% | +$397K |
|
2574
Wave Life Sciences
WVE
$1.09B
| $1.2M | ﹤0.01% |
115,235
-6,226
| -5% | -$58.6K |
|
2575
Kiniksa Pharmaceuticals
KNSA
$5.8B
| $1.2M | ﹤0.01% |
47,047
+11,551
| +33% | +$241K |
|
Similar funds
Charles Schwab's Q2 2020 Portfolio in Review
As of Q2 2020, Charles Schwab held 3,435 positions worth $204B, up 20% from $170B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2020 filing shows 201 new, 1,862 increased, 1,124 reduced and 116 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M. The largest sale was Intel, an estimated $589M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2020 buy was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M.
- Charles Schwab added most to iShares Core S&P 500 ETF in Q2 2020, an estimated $461M increase.
- Charles Schwab's biggest Q2 2020 reduction was Intel, cutting an estimated $589M.
- Charles Schwab fully exited Raytheon Company in Q2 2020, selling an estimated $373M.
- Charles Schwab's ten largest holdings make up 17% of its $204B portfolio in Q2 2020.
- Charles Schwab opened 201 new positions and closed 116 in Q2 2020.
- Charles Schwab's portfolio value rose 20% quarter-over-quarter to $204B.
Based on Charles Schwab's 13F filing for Q2 2020, filed 14 Aug 2020.